RSV vaccine (Themis/Institut Pasteur)

N/A

Report date: 2025/03/19 18:25:34

Base Information

Drug NameRSV vaccine (Themis/Institut Pasteur)
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThemis Bioscience Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesThemis Bioscience GmbhInstitut Pasteur
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A